Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03798470 · ClinicalTrials.gov registry record · NA

FAVOR Opioid Recovery Coaching Evaluation

A NA study, sponsored by Prisma Health-Upstate.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT03798470: Completed NA study, sponsored by Prisma Health-Upstate.

NCT03798470 is a NA study that has completed, run by Prisma Health-Upstate. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03798470, a NA study, has completed, sponsored by Prisma Health-Upstate.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

The Emergency Department (ED) is an ideal location to identify patients in need of treatment for opioid addiction. A local non-profit community-based addiction recovery program, Faces and Voices of Recovery (FAVOR) utilizes a peer recovery coaching model applied to substance use disorders by identifying, training, credentialing and supervising individuals who have been in recovery for at least 2 years. These peer recovery coaches become the primary workforce in this community-based model. FAVOR provides no-cost comprehensive services for addiction recovery. The investigators hypothesized that having FAVOR Recovery Coaches (FRC) evaluate patients during an ED visit for opioid overdose would result in a high degree of engagement from the patients and serve as an opportunity to begin treatment for addiction.

Primary Outcome

Defined as: Patients who have had phone, email, or in-person contact with their FAVOR recovery coach after discharge from the Emergency Department.

Interventions

  • BEHAVIORAL Peer Addiction Counseling

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2018-01-01
Est. Completion 2018-12-31
Phase NA
Prisma Health-Upstate

67 total trials

What the finished NCT03798470 record still lists

NCT03798470 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which Peer Addiction Counseling is the first listed.

NCT03798470 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03798470 about?

NCT03798470 is a clinical study titled "FAVOR Opioid Recovery Coaching Evaluation". The Emergency Department (ED) is an ideal location to identify patients in need of treatment for opioid addiction. A local non-profit community-based addiction recovery program, Faces and Voices of Recovery (FAVOR) utilizes a peer recovery coaching model applied to substance use disorders by identif...

What is the current status of trial NCT03798470?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2018-01-01. Estimated completion is 2018-12-31.

What interventions are being tested in trial NCT03798470?

The interventions under investigation include: Peer Addiction Counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT03798470?

This trial is sponsored by Prisma Health-Upstate, which has 67 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03798470's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03798470, the US trial registry maintained by the National Library of Medicine. NCT03798470 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.